Objectives: The aim of this study was to assess thrombotic complications following sclerotherapy in thrombophilic patients in combination with thromboprophylaxis, in two randomized arms using low molecular weight heparin (LMWH) or warfarin. Patients and methods This study received approval from the Ethics Committee. A total of 105 patients (81 females, 24 males) ranging in age from 20 to 82 years (mean 50) were selected: 75 with Factor V Leiden mutation, 18 with prothrombin 20210A mutation, 7 with high level of Factor VIII, 5 combinations of these. After randomization, 51 and 54 patients received warfarin and LMWH, respectively. A total of 199 sclerotherapy sessions were performed. Foam was used in 160 treatments.
Results: No episodes of symptomatic deep vein thrombosis (DVT) or pulmonary embolism (PE) occurred; no instances of DVT were revealed by ultrasound-monitoring.
Conclusions: This study suggests that in the three most common forms of thrombophilia, sclerotherapy, in combination with thromboprophylaxis, can be performed safely. Prophylaxis with LMWH is easier to use than warfarin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1258/phleb.2009.008081 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A clinical decision support tool for improving venous thromboembolism risk assessment and thromboprophylaxis prescribing compliance within an electronic medication management system: a retrospective observational study.
Int J Clin Pharm
January 2025
Pharmacy Department, Cabrini Health, 183 Wattletree Road Malvern, Malvern, VIC, 3144, Australia.
Background: Despite various interventions to improve best-practice venous thromboembolism (VTE) prevention measures within hospitals, compliance remains poor. For health services utilising electronic medication management systems (eMMS), implementation of clinical decision support (CDS) tools could address this gap.
Aim: To evaluate whether local implementation of an integrated electronic alert system linked with a computerised physician order entry (CPOE)-based order set for VTE risk assessment within an eMMS improves the rates of timely VTE risk assessment and guideline-compliant VTE prophylaxis prescribing among hospitalised patients.
How I treat quantitative fibrinogen disorders.
Blood
December 2024
Hôpitaux Universitaire de Genève, Geneva, Switzerland.
Quantitative fibrinogen disorders, including afibrinogenemia and hypofibrinogenemia, are defined by the complete absence or reduction of fibrinogen, respectively. The diagnosis is based on the measurement of fibrinogen activity and antigen levels, which define the severity of this monogenic disorder. Afibrinogenemia is the result of homozygosity or combined heterozygosity for the causative mutations, whereas monoallelic mutations lead to hypofibrinogenemia.
View Article and Find Full Text PDFEfficacy and safety of safflower yellow combined with low molecular weight heparin in preventing deep vein thrombosis after orthopedic surgery: a systematic review and meta-analysis.
Am J Transl Res
November 2024
Department of Pharmacy, Kunming Medical University Affiliated Yan'an Hospital Kunming 650051, Yunnan, China.
Objective: This systematic review and meta-analysis aims to evaluate the efficacy and safety of safflower yellow (SY) combined with low molecular weight heparin (LMWH) in preventing deep vein thrombosis (DVT) after orthopedic surgery.
Methods: We conducted a comprehensive investigation of PubMed, EMbase, Cochrane Library, CNKI, VIP, and Wanfang databases to identify randomized controlled trials (RCTs) from January 2000 to March 2024. These trials compared the efficacy of SY combined with LMWH versus LMWH alone in preventing post-surgical DVT.
Prevention and management of postoperative deep vein thrombosis in lower extremities of patients with gastrointestinal tumor.
World J Gastrointest Surg
October 2024
Department of Thyroid Surgery, Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan Province, China.
Article Synopsis
- - Deep vein thrombosis (DVT) poses a serious risk for patients after gastrointestinal cancer surgery, especially for those with higher age and body mass index (BMI); effective preventive measures are essential to avoid complications like DVT and pulmonary embolism (PE).
- - A study involving 100 patients assessed a combined DVT prevention protocol—including risk assessments, mechanical support, pharmacological intervention, and early mobilization—with the goal of determining its impact on reducing DVT rates post-surgery.
- - Results showed a 7% DVT incidence and a 1% occurrence of PE among participants, with a high adherence rate of 92% to the protocol; age, BMI, and longer surgery duration were identified as significant risk factors
Hidden costs of first choice alternatives: A financial model of thromboprophylaxis and prosthetic joint infection prophylaxis in total knee arthroplasty.
J Orthop
May 2025
Department of Adult Reconstruction and Joint Replacement, Hospital for Special Surgery, 535East 70th St, New York, NY, 10021, USA.
Background: Aspirin has been shown to be equally or more effective than factor Xa inhibitors for thromboprophylaxis following total knee arthroplasty (TKA). Cefazolin has been proven more effective than vancomycin in preventing prosthetic joint infection (PJI) after TKA. This study aimed to compare costs between different drug combinations for prevention of venous thromboembolism (VTE) and PJI following TKA, focusing on costs associated with PJI management.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!